IP Library Granted Patent US 11,123,565
Granted Patent B1
US 11,123,565 · App. 15/798,110 · Granted Sep 21, 2021

Treatment of neurodegenerative disease with high frequency stimulation, and associated systems and methods

Inventors: James R. Thacker (Homer, AK); Kerry Bradley (Glendale, CA); Dongchul Lee (Agua Dulce, CA)
Assignee: Nevro Corp.
A61N1/36171A61N1/06A61N1/36062A61N1/36082A61N1/36175
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,123,565
App. No.
15/798,110
Granted
Sep 21, 2021
Kind
B1
Abstract

Systems and methods for treating neurodegenerative disorders with high frequency stimulation are disclosed. A representative method for treating a patient includes applying an electrical signal to the patient via a treatment system that includes a signal delivery element positioned at or within a white matter of the patient's brain, spinal cord, or both, the electrical signal having a frequency of from about 1.5 kHz to about 100 kHz.

Claims (18)

1. A method for treating a patient, comprising:

addressing a neurodegenerative disease in the patient by applying an electrical signal to the patient via a treatment system that includes a signal delivery element positioned at or within white matter of the patient's brain, the electrical signal having a frequency of from about 5 kHz to about 100 kHz.

2. The method of claim 1 wherein applying the electrical signal includes applying the electrical signal to one or more glial cells present in the white matter at or proximate the signal delivery element.

3. The method of claim 2 wherein applying the electrical signal to the one or more glial cells includes applying the electrical signal to one or more astrocytes in the white matter at or proximate the signal delivery element.

4. The method of claim 1 wherein the electrical signal has a frequency of at least 50 kHz.

5. The method of claim 1 wherein applying the electrical signal includes modulating ion-pump activity of one or more neurons and/or glial cells within the white matter of the brain without the use of ATP.

6. The method of claim 1 wherein applying the electrical signal includes applying the electrical signal to a signal delivery element positioned at the hippocampus.

7. The method of claim 1 wherein applying the electrical signal includes applying the electrical signal having a pulse width of from about 10 μs to about 30 μs.

8. A method for treating a neurodegenerative disease of a patient, comprising:

in response to an indication of a degenerative lesion within white matter of the patient's brain, applying an electrical signal to the patient via a treatment system that includes a signal delivery element positioned at or proximate the lesion and in electrical communication with the lesion, the electrical signal having a frequency of from about 5 kHz to about 100 kHz.

9. The method of claim 8 wherein applying the electrical signal includes applying the electrical signal to one or more astrocytes in the white matter at or proximate the signal delivery element.

10. The method of claim 8 wherein the electrical signal has a frequency of at least 50 kHz.

11. The method of claim 8 wherein applying the electrical signal includes modulating ion-pump activity of one or more neurons and/or glial cells within the white matter of the brain.

12. The method of claim 11 wherein applying the electrical signal includes activating one or more ion-pumps of the one or more neurons and/or glial cells via application of the electrical signal and without the use of ATP.

13. The method of claim 8 wherein applying the electrical signal includes applying the electrical signal having a pulse width of from about 10 μs to about 30 μs.

14. A method for treating a patient, comprising:

addressing a neurodegenerative disease in the patient by applying an electrical signal to the patient via a treatment system that includes a signal delivery element positioned at or within white matter of the patient's brain, wherein the electrical signal is applied to one or more astrocytes present in the white matter at or proximate the signal delivery element, the electrical signal having a frequency of at least 50 kHz,

wherein applying the electrical signal includes modulating ion-pump activity of one or more neurons and/or glial cells within the white matter of the brain without the use of ATP.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2019
From: THACKER, JAMES R.; BRADLEY, KERRY; LEE, DONGCHUL
To: NEVRO CORP.
Reel/Frame 050391/0914 →
Continuity (1)
Provisional Application 62415429 · Oct 31, 2016
Cited By (2)
US 12,447,333 US 12,661,516